Back to 
CLIFFORD SWAN INVESTMENT COUNSEL LLC
CLIFFORD SWAN INVESTMENT COUNSEL LLC
AZN
Showing 0 of 3 quarters
Position history for CLIFFORD SWAN INVESTMENT COUNSEL LLC's holdings in ASTRAZENECA PLC
No. Clifford Swan Investment Counsel exited its AZN (AstraZeneca) position in Q3 2019. Its Q2 2019 13F listed 7,096 shares worth $293,000. Clifford Swan Investment Counsel already held AZN in its Q1 2019 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.